Boc-L-Orn(Boc)-OH

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP25909

CAS No:57133-29-6

Synonyms/Alias:N-(3-Indolylacetyl)-L-isoleucine;57105-45-0;IAA-Ile;(2S,3S)-2-[2-(1H-INDOL-3-YL)ACETAMIDO]-3-METHYLPENTANOICACID;AmbotzIAA1000;IAA-L-Ile;L-isoleucine,N-(1H-indol-3-ylacetyl)-;AC1LD8T0;SCHEMBL503296;CTK5A6293;ZINC56769;MolPort-008-268-144;N-(1H-Indole-3-ylacetyl)isoleucine;AKOS010367623;AM025933;AN-40004;HE058421;TC-166023;L-Isoleucine,N-[2-(1H-indol-3-yl)acetyl]-;L-Isoleucine,N-(1H-indol-3-ylacetyl)-(9CI);(2S,3S)-2-[[2-(1H-indol-3-yl)acetyl]amino]-3-methyl-pentanoicacid;(2S,3S)-2-[[2-(1H-indol-3-yl)acetyl]amino]-3-methylpentanoicacid

Chemical Name:N-Alpha-N-Di-(t-butyloxycarbonyl)-L-ornithine

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C16H20N2O3
M.W/Mr.
332,4 g/mole

Boc-L-Orn(Boc)-OH is a protected L-ornithine derivative bearing an N-terminal Boc group and an additional Boc-protected side-chain amino functionality, providing a doubly protected, amine-rich amino acid building block for controlled peptide assembly. This protected ornithine scaffold is commonly used in workflows that require orthogonal or sequential deprotection to manage reactivity of primary amines during synthesis and downstream coupling steps.

1. Solid-Phase Peptide Synthesis

Boc-L-Orn(Boc)-OH is used as a protected amino acid building block for constructing peptide sequences that incorporate ornithine residues while minimizing side reactions from free primary amines. Peptide synthesis teams select this doubly Boc-protected form to keep both the α-amino group and the side-chain amino group masked during chain elongation, supporting cleaner coupling and reducing undesired branching or cross-coupling. After peptide assembly, the controlled removal of Boc protecting groups enables subsequent functionalization at the ornithine side chain in the context of custom peptide manufacturing and research-grade peptide library workflows.

2. Orthogonally Protected Ornithine Segments

Boc-L-Orn(Boc)-OH is frequently incorporated into segment condensation and modular peptide assembly strategies where ornithine functionality must remain dormant until a later stage. By keeping the side-chain amine protected as a Boc group alongside the N-terminal Boc, this reagent supports stepwise synthesis designs in which the ornithine position is introduced as a stable intermediate and then selectively deprotected for further derivatization. Medicinal chemistry and chemical biology groups use this approach when building peptidomimetic scaffolds, constrained side-chain variants, or ornithine-containing intermediates that require precise control over which amine participates in the next coupling or derivatization event.

3. Peptide Derivatization Intermediates

Boc-L-Orn(Boc)-OH serves as a practical precursor for preparing ornithine-containing peptide intermediates used in downstream chemical modification workflows. Researchers often rely on this protected form to generate peptides bearing a masked side-chain amine that can be unveiled after synthesis for attachment of linkers, tags, or other functional substituents under conditions compatible with the rest of the peptide. In protein science and chemical biology settings, this enables controlled generation of amine-reactive peptide derivatives while limiting premature reactivity during assembly, purification, and handling of complex peptide constructs.

4. Pharmaceutical Intermediate Building Block

Boc-L-Orn(Boc)-OH is also used in pharmaceutical intermediate development where protected ornithine units are required as amine-rich building blocks for the synthesis of peptidic or peptidomimetic intermediates. Process development chemists and custom synthesis teams select the doubly Boc-protected reagent to improve handling stability and to reduce side reactions associated with unprotected primary amines during multi-step coupling and purification sequences. This protected ornithine scaffold supports manufacturing-oriented workflows that require reliable protection of both amino sites until the planned deprotection and subsequent functionalization steps in the intermediate route.

Size
5 g;25 g;
InChI
1S/C16H20N2O3/c1-3-10(2)15(16(20)21)18-14(19)8-11-9-17-13-7-5-4-6-12(11)13/h4-7,9-10,15,17H,3,8H2,1-2H3,(H,18,19)(H,20,21)/t10-,15-/m0/s1
InChI Key
WPTUQMUCTTVOFW-BONVTDFDSA-N
Canonical SMILES
CCC(C)C(C(=O)O)NC(=O)CC1=CNC2=CC=CC=C21

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceCustom Conjugation ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesEpitope Mapping ServicesPeptide CDMOPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers